The Wisconsin Innovation Index is your guide to Wisconsin’s entrepreneurial assets. It maps our statewide corporate network of investors, incubators, accelerators, academic resources, professional service firms, regional  economic development groups and government resources tied to the growth of Wisconsin’s high-tech economy.

Arrowhead Research Corporation

Work 465 Science Drive, Suite C Madison WI 53711 Work Phone: (608) 316-3890 Website: http://www.arrowheadresearch.com/


No Image Available

Arrowhead Research Corporation develops novel drugs to treat intractable diseases by silencing the genes that cause them. Using the broadest portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. Arrowhead’s most advanced drug candidate in clinical development is ARC-520, which is designed to treat chronic hepatitis B infection by inhibiting the production of all HBV gene products.  The goal is to reverse the immune suppression that prevents the body from controlling the virus and clearing the disease. Arrowhead’s second clinical candidate is ARC-AAT, a treatment for a rare liver disease associated with a genetic disorder that causes alpha-1 antitrypsin deficiency.

Connections Business Directory | Leaflet | © OpenStreetMap contributors

465 Science Drive, Suite C Madison WI 53711